TriNetX has chosen Harvard Medical School Associate Professor Jeffrey Brown, Ph.D., as Scientific Director.
The real-world data expert joined the research network provider on Monday after 16 years at Harvard, where he worked in the department of population medicine. He has been a consultant to research groups and pharmaceutical companies for real-world data studies, including assisting with research to support regulatory filings in the United States and Europe, the company noted On Monday.
The FDA, the National Institutes of Health, the National Cancer Institute, and other groups have helped fund Brown’s research. The executive also worked with TriNetX as the co-chair of its strategic advisory board for “several years,” Brown said in a statement. He is also the product manager of the open source software network PopMedNet, according to his LinkedIn page.
Brown said he would help TriNetX use its data to support customers in the areas of pre- and post-market safety, pharmacovigilance, health economics and other areas.
RELATED: Investment Firm The Carlyle Group Takes Majority Stake in TriNetX Trend
TriNetX is right next to Harvard in Cambridge, Massachusetts, and counts CROs and biopharmas as clients. Its platform is used by researchers to examine patient populations, perform analyzes, and assist with various stages of clinical trials, including protocol design, trial site selection, patient recruitment, and evidence. concrete.
The company is a partner of Medidata, Datavant, Mediclinic Middle East and others.
The Carlyle Group bought a controlling stake in the company last September.